An Uninformative Truth: The Logic of Amarin's Off-Label Promotion.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 26978686.
- Also identified by DOI 10.1371/journal.pmed.1001978 and PMC identifier 4792458.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Spencer Phillips Hey and Aaron Kesselheim propose that informativeness-asserting scientific facts-rather than truthfulness ought to be the standard for regulating commercial speech about pharmaceuticals.
Medical subject headings
- Drug Approval
- Drug Industry
- Eicosapentaenoic Acid
- Hypertriglyceridemia
- Hypolipidemic Agents
- Marketing
- Off-Label Use
- United States Food and Drug Administration